Moors & Cabot, Inc. Organogenesis Holdings Inc. Transaction History

Moors & Cabot, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Dec 08, 2021	BUY	$13.71 - $17.18 $772,558 - $968,093	56,350 Added 563.5%	66,350 $945,000
Q3 2021 Nov 05, 2021	SELL	$13.71 - $17.18 $772,558 - $968,093	-56,350 Reduced 84.93%	10,000 $11,000
Q2 2021 Aug 10, 2021	SELL	$14.92 - $23.23 $373,000 - $580,750	-25,000 Reduced 27.37%	66,350 $1.1 Million
Q2 2019 Jul 18, 2019	BUY	$6.58 - $8.69 $601,083 - $793,831	91,350 New	91,350 $694,000

118

64.3M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $437M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

Stay updated on Moors & Cabot, Inc. with notifications on news.